Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types

Allelic loss is a hallmark of tumor suppressor gene (TSG) inactivation. We have allelotyped 29 paired lymphoblastoid and lung cancer cell lines derived from 11 patients with small cell (SCLC) and 18 patients with non‐small cell lung carcinomas (NSCLC). Statistical analysis indicated that a threshold of 30% separated non‐random allelic loss from the random genetic deletions of malignancy. We have identified non‐random allelic loss at 42 of 54 (78%) specific chromosomal regions examined, with 22 regions (52%) common between the two major lung cancer histologic types. There were 3 regions (7%) with allelic loss specific for SCLC and 17 regions (41%) specific for NSCLC. Furthermore, there were significant differences in loss of heterozygosity (LOH) frequencies between NSCLC and SCLC at 13 regions on eight chromosome arms (3p, 5q, 6q, 9p, 10q, 11p, 13q, and 19p). Eight homozygous deletions were present in seven cell lines at four regions, 3p12, 3p14.2, 9p21, and 10q23–25. We have also identified novel sites of chromosomal deletions. In particular, there was frequent loss at 11p13 in SCLC and loss at 6p21.3 and 13q12.3 in NSCLC. In this study, we demonstrate that a) non‐random allelic losses in lung cancer involve multiple regions; b) some losses are common to both NSCLC and SCLC subtypes, whereas others are subtype specific; c) there are genetic deletions at novel chromosomal regions; and d) several homozygous deletions have been noted. Our studies demonstrate the usefulness of continuous cell lines for detailed allelotyping, for comparing genetic abnormalities between SCLC and NSCLC, and for identifying homozygous deletions. Genes Chromosomes Cancer 21:308–319, 1998. © 1998 Wiley‐Liss, Inc.

[1]  G. Giaccone,et al.  FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations. , 1997, Cancer research.

[2]  B. Johansson,et al.  A breakpoint map of recurrent chromosomal rearrangements in human neoplasia , 1997, Nature Genetics.

[3]  W. K. Alfred Yung,et al.  Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers , 1997, Nature Genetics.

[4]  M. Wigler,et al.  PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.

[5]  S. Hirohashi,et al.  Deletion of three distinct regions on chromosome 13q in human non‐small‐cell lung cancer , 1997, International journal of cancer.

[6]  A. Thor,et al.  Loss of Heterozygosity in Normal Tissue Adjacent to Breast Carcinomas , 1996, Science.

[7]  D A Meyers,et al.  Major Susceptibility Locus for Prostate Cancer on Chromosome 1 Suggested by a Genome-Wide Search , 1996, Science.

[8]  Irene L Andrulis,et al.  MADR2 Maps to 18q21 and Encodes a TGFβ–Regulated MAD–Related Protein That Is Functionally Mutated in Colorectal Carcinoma , 1996, Cell.

[9]  Y. Lu,et al.  2q-, a non-random chromosomal abnormality in human non-small-cell lung cancer. , 1996, Carcinogenesis.

[10]  I. Newsham,et al.  High-density marker analysis of 11p15.5 in non-small cell lung carcinomas reveals allelic deletion of one shared and one distinct region when compared to breast carcinomas. , 1996, Cancer research.

[11]  I. Campbell,et al.  Loss of heterozygosity on chromosome 5q in ovarian cancer is frequently accompanied by TP53 mutation and identifies a tumour suppressor gene locus at 5q13.1-21. , 1996, British Journal of Cancer.

[12]  R. Tampé,et al.  A functionally defective allele of TAP1 results in loss of MHC class I antigen presentation in a human lung cancer , 1996, Nature Genetics.

[13]  D Komitowski,et al.  Allelic imbalance on chromosome 13q: evidence for the involvement of BRCA2 and RB1 in sporadic breast cancer. , 1996, Cancer research.

[14]  J. Felix,et al.  Potential role of the inactivated X chromosome in ovarian epithelial tumor development. , 1996, Journal of the National Cancer Institute.

[15]  I. Petersen,et al.  Evidence for a novel tumor suppressor gene on chromosome 15 associated with progression to a metastatic stage in breast cancer. , 1996, Oncogene.

[16]  H. Koeffler,et al.  Frequent loss of heterozygosity in region of the KIP1 locus in non-small cell lung cancer: evidence for a new tumor suppressor gene on the short arm of chromosome 12. , 1996, Cancer research.

[17]  Scott E. Kern,et al.  DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1 , 1996, Science.

[18]  K. Arden,et al.  Allelic deletion mapping on chromosome 5 in human carcinomas. , 1996, Oncogene.

[19]  A. Gazdar,et al.  Cell culture methods for the establishment of the NCI series of lung cancer cell lines , 1996, Journal of cellular biochemistry. Supplement.

[20]  L. Thiberville,et al.  Frequency and prognostic evaluation of 3p21‐22 allelic losses in non‐small‐cell lung cancer , 1995, International journal of cancer.

[21]  F. Collins,et al.  The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. , 1995, Human molecular genetics.

[22]  G. Bepler,et al.  Multiple chromosomal aberrations and 11p allelotyping in lung cancer cell lines. , 1995, Cancer genetics and cytogenetics.

[23]  Kathleen R. Cho,et al.  Frequency of homozygous deletion at p16/CDKN2 in primary human tumours , 1995, Nature Genetics.

[24]  C. Croce,et al.  Loss of heterozygosity at chromosome 11q in lung adenocarcinoma: identification of three independent regions. , 1995, Cancer research.

[25]  A. Sahin,et al.  Comparative allelotype of in situ and invasive human breast cancer: high frequency of microsatellite instability in lobular breast carcinomas. , 1995, Cancer research.

[26]  J. Field,et al.  Loss of heterozygosity at 9p23 defines a novel locus in non-small cell lung cancer. , 1995, Oncogene.

[27]  T. Polascik,et al.  Novel suppressor loci on chromosome 14q in primary bladder cancer. , 1995, Cancer research.

[28]  B. Neyns,et al.  Frequent deletion of chromosome 19 and a rare rearrangement of 19p13.3 involving the insulin receptor gene in human ovarian cancer. , 1995, Oncogene.

[29]  J. Gray,et al.  Identification of novel regions of altered DNA copy number in small cell lung tumors , 1995, Genes, chromosomes & cancer.

[30]  T. Sekiya,et al.  Allelic losses in human chromosome II in lung cancers , 1995, Genes, chromosomes & cancer.

[31]  J. Varley,et al.  Frequent alterations of chromosome 1 in ductal carcinoma in situ of the breast. , 1995, Oncogene.

[32]  V. Ganju,et al.  Region‐specific loss of heterozygosity on chromosome 19 is related to the morphologic type of human glioma , 1995, Genes, chromosomes & cancer.

[33]  F. Speleman,et al.  Evidence for two tumour suppressor loci on chromosomal bands 1p35-36 involved in neuroblastoma: one probably imprinted, another associated with N-myc amplification. , 1995, Human molecular genetics.

[34]  C W Caldwell,et al.  Genetic alterations of microsatellites on chromosome 18 in human breast carcinoma. , 1995, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[35]  J. Minna,et al.  Mapping of the pulmonary surfactant SP5 (SFTP2) locus to 8p21 and characterization of a microsatellite repeat marker that shows frequent loss of heterozygosity in human carcinomas. , 1994, Genomics.

[36]  Y. Nakamura,et al.  Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung. , 1994, Cancer research.

[37]  L. Cawkwell,et al.  Frequency of allele loss of DCC, p53, RBI, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction. , 1994, British Journal of Cancer.

[38]  J. Yokota,et al.  Frequent allelic losses on chromosomes 2q, 18q, and 22q in advanced non-small cell lung carcinoma. , 1994, Cancer research.

[39]  Y S Erozan,et al.  Microsatellite alterations as clonal markers for the detection of human cancer. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[40]  J. Gray,et al.  Identification of frequent novel genetic alterations in small cell lung carcinoma. , 1994, Cancer research.

[41]  H. Sasaki,et al.  Allelotype of endometrial carcinoma. , 1994, Cancer research.

[42]  Yusuke Nakamura,et al.  Allelotype study of esophageal carcinoma , 1994, Genes, chromosomes & cancer.

[43]  S. Baylin,et al.  Homozygous deletion on chromosome 9p and loss of heterozygosity on 9q, 6p, and 6q in primary human small cell lung cancer. , 1994, Cancer research.

[44]  A. Balmain,et al.  An allelotype of squamous carcinoma of the head and neck using microsatellite markers. , 1994, Cancer research.

[45]  M. Carrington,et al.  A polymorphic dinucleotide repeat in the third intron of TAP1. , 1994, Human molecular genetics.

[46]  F. Kaye,et al.  Absence of p16INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB. , 1994, Oncogene.

[47]  J. Yokota,et al.  Homozygous deletion at chromosome 2q33 in human small-cell lung carcinoma identified by arbitrarily primed PCR genomic fingerprinting. , 1994, Oncogene.

[48]  T. L. McGee,et al.  Complete genomic sequence of the human retinoblastoma susceptibility gene. , 1993, Genomics.

[49]  M. Knowles,et al.  Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms. , 1993, Oncogene.

[50]  R. Brent,et al.  Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites , 1993, Cell.

[51]  K. Tory,et al.  Molecular characterization of a large homozygous deletion in the small cell lung cancer cell line U2020: A strategy for cloning the putative tumor suppressor gene , 1992, Genes, chromosomes & cancer.

[52]  Y. Nakamura,et al.  Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism , 1992, Genes, chromosomes & cancer.

[53]  Y. Nakamura,et al.  Allelotype of non-small cell lung carcinoma--comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma. , 1992, Cancer research.

[54]  J. Weber,et al.  Survey of human and rat microsatellites. , 1992, Genomics.

[55]  J. Minna,et al.  Polymorphic sites within the MCC and APC loci reveal very frequent loss of heterozygosity in human small cell lung cancer. , 1992, Cancer research.

[56]  R. Ueda,et al.  The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution pattern. , 1991, Oncogene.

[57]  J. Mattick,et al.  'Touchdown' PCR to circumvent spurious priming during gene amplification. , 1991, Nucleic acids research.

[58]  J. Minna,et al.  Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group. , 1990, Oncogene.

[59]  F. Collins,et al.  A submicroscopic homozygous deletion at the D3S3 locus in a cell line isolated from a small cell lung carcinoma , 1990, Genes, chromosomes & cancer.

[60]  C. E. Hildebrand,et al.  Physical mapping of human chromosomes by repetitive sequence fingerprinting. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[61]  L. Irving,et al.  Cytogenetics of non‐small cell lung cancer: Analysis of consistent non‐random abnormalities , 1990, Genes, chromosomes & cancer.

[62]  Y. Nakamura,et al.  Allelotype of colorectal carcinomas. , 1989, Science.

[63]  M. Litt,et al.  A hypervariable microsatellite revealed by in vitro amplification of a dinucleotide repeat within the cardiac muscle actin gene. , 1989, American journal of human genetics.

[64]  J. Minna,et al.  Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer , 1985, The Journal of experimental medicine.